(Q34343330)

1 August 2017

1 reference

title

Advancements in cancer therapy with alpha-emitters: a review (English)

1 reference

1 August 2017

S K Imam

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

International Journal of Radiation Oncology Biology Physics

1 August 2017

published in

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

271-278

1 reference

Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Radioimmunotherapy with alpha-emitting nuclides

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Vascular targeted radioimmunotherapy with 213Bi--an alpha-particle emitter

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

The feasibility of 225Ac as a source of alpha-particles in radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Radionuclides for radioimmunotherapy: criteria for selection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Synthesis, conjugation, and radiolabeling of a novel bifunctional chelating agent for (225)Ac radioimmunotherapy applications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Alpha- and beta-emitting radiolanthanides in targeted cancer therapy: the potential role of terbium-149

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Microdosimetric concepts in radioimmunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Analytic microdosimetry for radioimmunotherapeutic alpha emitters

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Radiobiology of alpha particles. III. Cell inactivation by alpha-particle traversals of the cell nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Radioimmunotherapy of malignancy using antibody targeted radionuclides

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

212Bismuth Linked to an Antipancreatic Carcinoma Antibody: Model for Alpha-Particle-Emitter Radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Cytotoxicity of 213Bi- and 225Ac-immunoconjugates.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901585-1

7 January 2021

10.1016/S0360-3016(01)01585-1

Identifiers

DOI

1 reference

1 August 2017

1 reference